1. Díaz-Casado, Elena, Gómez-Nieto, Ricardo, de Pereda, José M, Jara-Acevedo, María, López, Dolores E. 2020. Analysis of gene variants in the GASH/Sal model of epilepsy. In PloS one, 15, e0229953. doi:10.1371/journal.pone.0229953. https://pubmed.ncbi.nlm.nih.gov/32168507/
2. Jia, Guochong, Ping, Jie, Guo, Xingyi, Haiman, Christopher A, Zheng, Wei. 2024. Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction. In Nature genetics, 56, 819-826. doi:10.1038/s41588-024-01736-4. https://pubmed.ncbi.nlm.nih.gov/38741014/
3. Liu, Kun, Wang, Aixiang, Ran, Longke, Sen, Wang, Song, Fangzhou. 2019. ARHGEF38 as a novel biomarker to predict aggressive prostate cancer. In Genes & diseases, 7, 217-224. doi:10.1016/j.gendis.2019.03.004. https://pubmed.ncbi.nlm.nih.gov/32215291/
4. Lansdon, Lisa A, Dickinson, Amanda, Arlis, Sydney, Murray, Jeffrey C, Manak, J Robert. 2022. Genome-wide analysis of copy-number variation in humans with cleft lip and/or cleft palate identifies COBLL1, RIC1, and ARHGEF38 as clefting genes. In American journal of human genetics, 110, 71-91. doi:10.1016/j.ajhg.2022.11.012. https://pubmed.ncbi.nlm.nih.gov/36493769/
5. Liang, Xiangdong, Wang, Yanchao, Pei, Long, Tan, Xiaoliang, Dong, Chunhui. 2022. Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis. In Frontiers in surgery, 9, 856446. doi:10.3389/fsurg.2022.856446. https://pubmed.ncbi.nlm.nih.gov/35372462/
智鼠故事 
